摘要 |
A combination therapy is provided of IFN-gamma and therapeutic antibodies that recognize determinants on hyperproliferative B lineage cells. The targeted cells are contacted with these agents either locally or systematically, usually systematically. The subject methods provide a means for therapeutic treatment and investigation of hyperproliferative disorders.
|